Avidity Biosciences, Inc.
RNA
$71.53
-$0.06-0.08%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 224.28% | 144.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 224.28% | 144.56% | |||
| Cost of Revenue | 12.18% | 38.83% | |||
| Gross Profit | -6.10% | -37.13% | |||
| SG&A Expenses | 25.69% | 9.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.02% | 31.48% | |||
| Operating Income | -10.32% | -30.13% | |||
| Income Before Tax | -10.89% | -35.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.89% | -35.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.89% | -35.88% | |||
| EBIT | -10.32% | -30.13% | |||
| EBITDA | -10.23% | -30.29% | |||
| EPS Basic | -4.24% | -35.46% | |||
| Normalized Basic EPS | -4.23% | -35.47% | |||
| EPS Diluted | -4.24% | -34.84% | |||
| Normalized Diluted EPS | -4.23% | -35.47% | |||
| Average Basic Shares Outstanding | 6.38% | 0.30% | |||
| Average Diluted Shares Outstanding | 6.38% | 0.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||